StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$1.91−0.09 (-4.50%)

Close on Nov 18, 2026Market cap $75.35MP/E –Yield –

Sera Prognostics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Sera Prognostics's free cash flow for the twelve months ending Jun 30, 2026 was -$28.15M. For fiscal 2025 it was -$26.35M. The highest annual figure on record is -$14.25M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$26.35M–
FY2024Dec 31, 2024-$14.25M–
FY2023Dec 31, 2023-$27.32M–
FY2022Dec 31, 2022-$35.40M–
FY2021Dec 31, 2021-$32.94M–
FY2020Dec 31, 2020-$17.02M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.33M–
Q1 FY2026Mar 31, 2026-$8.78M–
Q4 FY2025Dec 31, 2025-$6.45M–
Q3 FY2025Sep 30, 2025-$6.59M–
Q2 FY2025Jun 30, 2025-$5.75M–
Q1 FY2025Mar 31, 2025-$7.56M-251.8%
Q4 FY2024Dec 31, 2024-$6.27M–
Q3 FY2024Sep 30, 2024-$7.02M–
Q2 FY2024Jun 30, 2024-$5.94M–
Q1 FY2024Mar 31, 2024$4.98M–
Q4 FY2023Dec 31, 2023-$6.78M–
Q3 FY2023Sep 30, 2023-$7.62M–
Q2 FY2023Jun 30, 2023-$8.00M–
Q1 FY2023Mar 31, 2023-$4.92M–
Q4 FY2022Dec 31, 2022-$7.43M–
Q3 FY2022Sep 30, 2022-$9.15M–
Q2 FY2022Jun 30, 2022-$9.26M–
Q1 FY2022Mar 31, 2022-$9.56M–
Q4 FY2021Dec 31, 2021-$9.90M–
Q3 FY2021Sep 30, 2021-$9.73M–
Q2 FY2021Jun 30, 2021-$6.32M–
Q1 FY2021Mar 31, 2021-$6.99M–
Q4 FY2020Dec 31, 2020-$4.23M–
Q3 FY2020Sep 30, 2020-$4.01M–

More Sera Prognostics figures

See a number that looks wrong?